Reveleer
Reveleer offers an AI-powered platform for value-based care, unifying retrieval, risk adjustment, quality improvement, and member management solutions.
Secondary Market Price
How Reveleer Measures Up
To help you manage your Reveleer equity, Prospect has run the company through our machine learning model.
Prospect Rating
--
This rating reflects our belief in this company's potential to grow to that many times its current value in 4 years. For an employee with stock, this rating suggests a potential return on equity, but it also comes with some risk.
Exit Risk
--
Our rating is a reflection of the likelihood of this company achieving a liquidity event for its employees based on the quality of investors, funding stage, founders, and more.
Funding Stage
TBD
A company’s funding stage reflects how established it is, how quickly it is scaling, and the average impact an employee may have when joining.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Reveleer's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Reveleer Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Reveleer's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Reveleer is a value-based care enablement partner that provides an AI-powered platform for health plans and provider organizations. The company’s system integrates data retrieval, clinical intelligence, risk adjustment, quality improvement, and member management to streamline workflows for its customers. Key offerings include solutions for both prospective and retrospective risk adjustment, as well as a member management tool for Medicare Advantage plans that automates enrollment, billing, and compliance. Founded in 2009 and also known as Health Data Vision, Reveleer is headquartered in Glendale, California, with an additional office in New Albany, Ohio.
The company is focused on expanding its AI capabilities, underscored by a recent partnership with Google Cloud to leverage technologies like Gemini and Vertex AI. This collaboration aims to standardize unstructured patient data and provide more explainable insights within physician workflows. Reveleer recently launched its EVE™ Hybrid AI engine for prospective risk adjustment and, as of March 2024, secured $65 million in debt financing. Recent operational milestones include processing over 26 million claims, contributing 9 million Continuity of Care Documents to national interoperability networks, and achieving a 2.4x year-over-year growth in lives covered by its platform.
- Oak HC/FT
- Upfront Ventures
- Boston Millennia Partners
- Hercules Capital, Inc.
- Co-Founder, CEO Brain Schimpf
- Co-Founder, Michael Klotz
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Reveleer worth joining?
Deciding whether to join a company like Reveleer involves evaluating the total compensation package, including the potential upside of its equity. Tools like Prospect can help you model the future value of your equity and compare it to opportunities at other companies.
What should I do with my Reveleer stock?
Managing your private company stock involves creating a personalized strategy for when to exercise options and when to sell, based on your financial goals and risk tolerance. Prospect offers customized option exercise strategies and tax optimization to help you maximize the value of your shares.
Can you sell Reveleer stock?
Selling stock in a private company like Reveleer is possible but typically restricted to specific events like tender offers or transactions on secondary markets. Platforms like Prospect provide tools and up-to-date pricing information to help you navigate these selling opportunities effectively.
How can I find the value of my Reveleer stock?
The value of private stock is formally determined by a 409A valuation, but its future worth can be projected using various data points. Prospect uses proprietary predictive models, trained on venture capital data, to help you forecast the potential future value of your equity.
What is Reveleer's equity worth?
The worth of equity in a private company like Reveleer depends on factors like its last valuation, growth trajectory, and overall market conditions. To understand what your specific holdings might be worth, Prospect can model different scenarios and project a range of likely outcomes for your shares.
What is Reveleer's stock ticker symbol?
As a private company, Reveleer is not traded on a public stock exchange and therefore does not have a stock ticker symbol. Ticker symbols are assigned only when a company completes an Initial Public Offering (IPO) and lists on an exchange like the NYSE or NASDAQ.
Can I buy or sell Reveleer stock?
Buying or selling stock in a private company like Reveleer is generally restricted and not as simple as trading public stocks. For employees, platforms like Prospect offer guidance and tools to navigate selling opportunities in a tax-optimal way.
What is the criteria to buy or invest in Reveleer stock?
Investing in a private company like Reveleer is typically limited to institutional investors or individuals who meet the SEC's criteria for being an accredited investor. These investments are usually made through direct funding rounds or by purchasing shares on specialized secondary markets.
